E-LIB Suche - Ergebnisse für: Lewis, Lionel D.

1

Clinical and research updates on the VISTA immune checkpoin..:

Noelle, Randolph J. ; Lines, J. Louise ; Lewis, Lionel D....
Frontiers in Oncology. 13 (2023) - p. , 2023

2

Phase I study to assess the effect of adavosertib (AZD1775)..:

Någård, Mats ; Ah-See, Mei-Lin ; Strauss, James...
Cancer Chemotherapy and Pharmacology. 92 (2023) 3 - p. 193-203 , 2023

Link: https://doi.org/10.1007/..

3

VISTA expression and patient selection for immune-based ant..:

Martin, Alexander S. ; Molloy, Michael ; Ugolkov, Andrey...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Dexamethasone to prevent everolimus-induced stomatitis (All..:

Ruddy, Kathryn J. ; Zahrieh, David ; He, Jun...
Seminars in Oncology. 50 (2023) 1-2 - p. 7-10 , 2023

Link: https://doi.org/10.1053/..

5

Pharmacokinetics and pharmacodynamics of Hedgehog pathway i..:

Lear, John T. ; Morris, Linda M. ; Ness, Dylan B..
Expert Review of Clinical Pharmacology. 16 (2023) 12 - p. 1211-1220 , 2023

Link: https://doi.org/10.1080/..

6

Potential Impact of Pharmacogenomic Single Nucleotide Varia..:

Williams, Grace R ; Tsongalis, Gregory J ; Lewis, Lionel D...
The Journal of Applied Laboratory Medicine. 8 (2023) 2 - p. 251-263 , 2023

Link: https://doi.org/10.1093/..

7

Adavosertib (AZD1775) does not prolong the QTc interval in ..:

Någård, Mats ; Ah-See, Mei-Lin ; Strauss, James...
Cancer Chemotherapy and Pharmacology. 92 (2023) 2 - p. 141-150 , 2023

Link: https://doi.org/10.1007/..

8

A phase II study of alternating sunitinib and temsirolimus ..:

Ness, Dylan B. ; Pooler, Darcy B. ; Ades, Steven...
Cancer Medicine. 12 (2023) 12 - p. 13100-13110 , 2023

Link: https://doi.org/10.1002/..

9

Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibi..:

De La Torre, Adrianna L. ; Huynh, Thao N. ; Chang, Catherine C. Y....
International Journal of Molecular Sciences. 24 (2023) 13 - p. 11013 , 2023

Link: https://doi.org/10.3390/..

10

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combi..:

Torka, Pallawi ; Kambhampati, Swetha ; Chen, Lu...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

11

Tumour, whole‐blood, plasma and tissue concentrations of me..:

Phillips, Joseph D. ; Pooler, Darcy B. ; Ness, Dylan B....
British Journal of Clinical Pharmacology. 89 (2022) 3 - p. 1027-1035 , 2022

Link: https://doi.org/10.1111/..

12

A phase I trial of BNC105P and ibrutinib in patients with r..:

Pooler, Darcy B. ; Ness, Dylan B. ; Danilov, Alexey V....
eJHaem. 3 (2022) 4 - p. 1445-1448 , 2022

Link: https://doi.org/10.1002/..

13

Spotlight commentary: Navigating between financial risks an..:

Likic, Robert ; Dear, James W. ; Lewis, Lionel D.
British Journal of Clinical Pharmacology. 88 (2022) 12 - p. 5060-5063 , 2022

Link: https://doi.org/10.1111/..

14

Dasatinib and dexamethasone followed by hematopoietic cell ..:

Wieduwilt, Matthew J. ; Yin, Jun ; Wetzler, Meir...
Blood Advances. 5 (2021) 22 - p. 4691-4700 , 2021

Link: https://doi.org/10.1182/..

15

Kynurenine‐Induced Aryl Hydrocarbon Receptor Signaling in M..:

Rojas, Itzel Y. ; Moyer, Benjamin J. ; Ringelberg, Carol S....
Obesity. 29 (2021) 2 - p. 337-349 , 2021

Link: https://doi.org/10.1002/..